Willingness to pay for oral cholera vaccines in urban Bangladesh [PDF]
PLoS ONE, 2020 Rashidul Alam Mahumud +2 more
exaly +2 more sources
Strategies for achieving a healthy oral cholera vaccine market: Model-enabled scenario exploration of supply and demand dynamics. [PDF]
PLoS Neglected Tropical DiseasesFollowing decades of progress, recent years have seen a resurgence of cholera. This has led to unprecedented demand for vaccines from the global emergency stockpile of oral cholera vaccines (OCVs), for outbreak and humanitarian use.
Donovan Guttieres +3 more
doaj +2 more sources
Systemic, Mucosal, and Memory Immune Responses following Cholera
Tropical Medicine and Infectious Disease, 2021 Vibrio cholerae O1, the major causative agent of cholera, remains a significant public health threat. Although there are available vaccines for cholera, the protection provided by killed whole-cell cholera vaccines in young children is poor.
Edward T. Ryan +11 more
doaj +1 more source
The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis [PDF]
PLoS Neglected Tropical Diseases, 2018 Abdur Razzaque Sarker +2 more
exaly +2 more sources
Journal of Travel Medicine, 2000 Cholera causes significant morbidity and mortality worldwide. For travelers, the risk of developing cholera per month of stay in a developing country is approximately 0.001%-0.01%, and cholera may present as traveler's diarrhea. In the United States, only a poorly tolerated, marginally effective, parenterally administered, phenol-inactivated vaccine is
E T, Ryan, S B, Calderwood
openaire +4 more sources
BMC Public Health, 2023 Background Cholera still affects millions of people worldwide, especially in lower- and middle-income countries (LMICs). The Global Task Force on Cholera Control (GTFCC) has identified surveillance and oral cholera vaccines as two critical interventions ...
Hanna Trolle +6 more
doaj +1 more source
Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development
Frontiers in Medicine, 2023 Vibrio cholerae is the causative agent of cholera, a highly contagious diarrheal disease affecting millions worldwide each year. Cholera is a major public health problem, primarily in countries with poor sanitary conditions and regions affected by ...
David A. Montero +12 more
doaj +1 more source
The effect of some avian pox vaccines on the immune response of turkey vaccinated with fowl cholera [PDF]
Veterinary Medical Journal - Giza, 2011 Live attenuated fowl cholera; fowl pox and pigeon pox vaccines were used to vaccinate turkey in a mutual manner. Six groups of turkeys (20 birds/group) were used.
Hanan Ibrahim +5 more
doaj +1 more source
Cholera pulse vaccination: A possible elimination strategy for cholera in endemic countries
Indian Journal of Public Health, 2021 Cholera is a diarrheal disease causing major health issue in developing countries where it is endemic and causes outbreaks. India ranks first with an estimated 675,188 number of cases and 20,256 number of deaths annually with one-third of its population ...
Neelam Taneja +3 more
doaj +1 more source
Cholera vaccine clinical trials: A cross-sectional analysis of clinical trials registries
Human Vaccines & Immunotherapeutics, 2023 Cholera has been one of the world’s biggest public health challenges for centuries. The presence of this disease brings into focus the social determinants of health in different parts of the world.
Lindi Mathebula +5 more
doaj +1 more source